MedPath

MIDNIGHT PHARMA, LLC

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

3 Phases

Phase 1:2
Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
1 (25.0%)
Phase 3
1 (25.0%)

Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users

First Posted Date
2013-11-19
Last Posted Date
2016-02-12
Lead Sponsor
Midnight Pharma, LLC
Target Recruit Count
42
Registration Number
NCT01987739

Almorexant in Primary Insomnia

Phase 1
Completed
Conditions
Insomnia
Primary Insomnia
Interventions
First Posted Date
2008-03-21
Last Posted Date
2016-02-12
Lead Sponsor
Midnight Pharma, LLC
Target Recruit Count
161
Registration Number
NCT00640848
Locations
🇦🇹

Medical University of Innsbruck, Dept. of Neurology Sleep Disorder Unit, Innsbruck, Austria

🇦🇹

Medical University of Vienna, Clinic of Neurology, Vienna, Austria

🇦🇹

Medical University of Vienna, University Clinic of Psychiatrie, Vienna, Austria

and more 24 locations

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

Phase 3
Completed
Conditions
Primary Insomnia
Interventions
First Posted Date
2008-02-06
Last Posted Date
2016-03-14
Lead Sponsor
Midnight Pharma, LLC
Target Recruit Count
709
Registration Number
NCT00608985
Locations
🇦🇺

Sleep Disorders Laboratory, Royal Adelaide Hospital, Adelaide, South Australia, Australia

🇦🇺

Monash Adult Sleep Center, Monash Medical Centre, Clayton, Victoria, Australia

🇦🇺

Western Hospitpal, Private Bag, Footscray, Victoria, Australia

and more 87 locations

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

Phase 2
Completed
Conditions
Chronic Primary Insomnia
Interventions
Drug: ACT-078573 and matching placebo
Drug: ACT-078573 oral capsules at 25 and 100 mg and matching placebo
First Posted Date
2008-02-04
Last Posted Date
2016-03-14
Lead Sponsor
Midnight Pharma, LLC
Target Recruit Count
112
Registration Number
NCT00606593
Locations
🇺🇸

Central Arkansas Research, Hot Springs, Arkansas, United States

🇺🇸

Pacific Sleep Medicine Services, Inc., San Diego, California, United States

🇺🇸

California Clinical Trials Medical Group, Inc., San Diego, California, United States

and more 17 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.